Venn Therapeutics: Next Generation Cancer Immunotherapy
Equities.com,
We've been following the progress of a privately held company called Venn Therapeutics that has been working to develop the…
Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells
Overview of attention for article published in Cancer Cell, April 2018
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
Average Attention Score compared to outputs of the same age and source
Mentioned by
- news
- 2 news outlets
- 40 X users
- patent
- 17 patents
- f1000
- 1 research highlight platform
Readers on
- mendeley
- 250 Mendeley
